CD86 Molecule Might Be a Novel Immune-Related Prognostic Biomarker for Patients With Bladder Cancer by Bioinformatics and Experimental Assays

As one of the most common malignancies in the urinary system, bladder cancer (BC) occupies a high mortality and recurrence rate. BC carries an ominous prognosis. Thus, we aimed to identify a novel immune-related prognostic biomarker and therapeutic target for immunotherapy in the present study. We f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xin, Du, Guo-Wei, Chen, Zhao, Liu, Tong-Zu, Li, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378807/
https://www.ncbi.nlm.nih.gov/pubmed/34422632
http://dx.doi.org/10.3389/fonc.2021.679851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378807/
https://www.ncbi.nlm.nih.gov/pubmed/34422632
http://dx.doi.org/10.3389/fonc.2021.679851

Ejemplares similares